Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hereditary Angioedema Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
IBio Inc
CSL Limited
Ionis Pharmaceuticals, Inc
Shire plc
BioCryst Pharmaceuticals, Inc
By Type:
Selective Bradykinin B2 Receptor Antagonist
C1 Esterase Inhibitor
Kallikrein Inhibitor
By Application:
Type I
Type III
Type II
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Hereditary Angioedema Drug Market Overview 2018-2029
-
1.1 China Hereditary Angioedema Drug Industry Development Overview
-
1.2 China Hereditary Angioedema Drug Industry Development History
-
1.3 China Hereditary Angioedema Drug Industry Market Size (2018-2029)
-
1.4 China Hereditary Angioedema Drug Market Analysis by Type from Production Side
-
1.4.1 China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of Selective Bradykinin B2 Receptor Antagonist (2018-2029)
-
1.4.2 China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of C1 Esterase Inhibitor (2018-2029)
-
1.4.3 China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of Kallikrein Inhibitor (2018-2029)
-
1.5 China Hereditary Angioedema Drug Market Analysis by Application from Consumption End
-
1.5.1 China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type I (2018-2029)
-
1.5.2 China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type III (2018-2029)
-
1.5.3 China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type II (2018-2029)
-
1.6 China Hereditary Angioedema Drug Market Analysis by Region
-
1.6.1 North China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Hereditary Angioedema Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Hereditary Angioedema Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Hereditary Angioedema Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Hereditary Angioedema Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Hereditary Angioedema Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Hereditary Angioedema Drug Industry Development
Chapter 3 Hereditary Angioedema DrugIndustry Chain Analysis
-
3.1 Hereditary Angioedema Drug Industry Chain
-
3.2 Hereditary Angioedema Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Hereditary Angioedema Drug Market
-
3.3 Hereditary Angioedema Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Hereditary Angioedema Drug Market
Chapter 4 China Hereditary Angioedema Drug Market, by Type
-
4.1 China Hereditary Angioedema Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Hereditary Angioedema Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Hereditary Angioedema Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Hereditary Angioedema Drug Production Volume and Growth Rate of Selective Bradykinin B2 Receptor Antagonist
-
4.5.2 China Hereditary Angioedema Drug Production Volume and Growth Rate of C1 Esterase Inhibitor
-
4.5.3 China Hereditary Angioedema Drug Production Volume and Growth Rate of Kallikrein Inhibitor
Chapter 5 China Hereditary Angioedema Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Hereditary Angioedema Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Hereditary Angioedema Drug Market Size and Growth Rate, by Application
-
5.5.1 China Hereditary Angioedema Drug Market Size and Growth Rate of Type I
-
5.5.2 China Hereditary Angioedema Drug Market Size and Growth Rate of Type III
-
5.5.3 China Hereditary Angioedema Drug Market Size and Growth Rate of Type II
Chapter 6 China Hereditary Angioedema Drug Market, by Region
-
6.1 China Hereditary Angioedema Drug Production Volume and Production Value, by Region
-
6.2 China Hereditary Angioedema Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Hereditary Angioedema Drug Market Analysis
-
7.1 North China Hereditary Angioedema Drug Market, by Type
-
7.2 North China Hereditary Angioedema Drug Market, by Application
Chapter 8 Central China Hereditary Angioedema Drug Market Analysis
-
8.1 Central China Hereditary Angioedema Drug Market, by Type
-
8.2 Central China Hereditary Angioedema Drug Market, by Application
Chapter 9 South China Hereditary Angioedema Drug Market Analysis
-
9.1 South China Hereditary Angioedema Drug Market, by Type
-
9.2 South China Hereditary Angioedema Drug Market, by Application
Chapter 10 East China Hereditary Angioedema Drug Market Analysis
-
10.1 East China Hereditary Angioedema Drug Market, by Type
-
10.2 East China Hereditary Angioedema Drug Market, by Application
Chapter 11 Northeast China Hereditary Angioedema Drug Market Analysis
-
11.1 Northeast China Hereditary Angioedema Drug Market, by Type
-
11.2 Northeast China Hereditary Angioedema Drug Market, by Application
Chapter 12 Southwest China Hereditary Angioedema Drug Market Analysis
-
12.1 Southwest China Hereditary Angioedema Drug Market, by Type
-
12.2 Southwest China Hereditary Angioedema Drug Market, by Application
Chapter 13 Northwest China Hereditary Angioedema Drug Market Analysis
-
13.1 Northwest China Hereditary Angioedema Drug Market, by Type
-
13.2 Northwest China Hereditary Angioedema Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 IBio Inc
-
14.1.1 IBio Inc Company Profile
-
14.1.2 IBio Inc Hereditary Angioedema Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 CSL Limited
-
14.2.1 CSL Limited Company Profile
-
14.2.2 CSL Limited Hereditary Angioedema Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Ionis Pharmaceuticals, Inc
-
14.3.1 Ionis Pharmaceuticals, Inc Company Profile
-
14.3.2 Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Shire plc
-
14.4.1 Shire plc Company Profile
-
14.4.2 Shire plc Hereditary Angioedema Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 BioCryst Pharmaceuticals, Inc
-
14.5.1 BioCryst Pharmaceuticals, Inc Company Profile
-
14.5.2 BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Market Performance
-
14.5.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Hereditary Angioedema Drug Industry Research Conclusions
-
15.2 Hereditary Angioedema Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Hereditary Angioedema Drug Industry Market Size (2018-2029)
-
Figure China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of Selective Bradykinin B2 Receptor Antagonist (2018-2029)
-
Figure China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of C1 Esterase Inhibitor (2018-2029)
-
Figure China Hereditary Angioedema Drug Production Volume, Production Value and Growth Rate of Kallikrein Inhibitor (2018-2029)
-
Figure China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type I (2018-2029)
-
Figure China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type III (2018-2029)
-
Figure China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate of Type II (2018-2029)
-
Figure North China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Hereditary Angioedema Drug Market Size and Growth Rate from 2018-2029
-
Figure Hereditary Angioedema Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Hereditary Angioedema Drug Market Share by Type in 2018
-
Figure China Hereditary Angioedema Drug Market Share by Type in 2023
-
Figure China Hereditary Angioedema Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Hereditary Angioedema Drug Production Volume and Growth Rate of Selective Bradykinin B2 Receptor Antagonist (2018-2023)
-
Figure China Hereditary Angioedema Drug Production Volume and Growth Rate of C1 Esterase Inhibitor (2018-2023)
-
Figure China Hereditary Angioedema Drug Production Volume and Growth Rate of Kallikrein Inhibitor (2018-2023)
-
Figure China Hereditary Angioedema Drug Market Share by Application in 2018
-
Figure China Hereditary Angioedema Drug Market Share by Application in 2023
-
Figure China Hereditary Angioedema Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Hereditary Angioedema Drug Market Size and Growth Rate of Type I (2018-2023)
-
Figure China Hereditary Angioedema Drug Market Size and Growth Rate of Type III (2018-2023)
-
Figure China Hereditary Angioedema Drug Market Size and Growth Rate of Type II (2018-2023)
-
Table China Hereditary Angioedema Drug Production Volume by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Production Volume Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Drug Production Volume Share by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Production Value by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Production Value Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Drug Production Value Share by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Sales Volume by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Sales Volume Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Drug Sales Volume Share by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Sales Value by Region (2018-2023)
-
Table China Hereditary Angioedema Drug Sales Value Share by Region (2018-2023)
-
Figure China Hereditary Angioedema Drug Sales Value Share by Region (2018-2023)
-
Table North China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table North China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure North China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table North China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table North China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table Central China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table Central China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table Central China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table South China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table South China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure South China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table South China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table South China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table East China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table East China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure East China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table East China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table East China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table Northeast China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table Southwest China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Hereditary Angioedema Drug Production Volume by Type (2018-2023)
-
Table Northwest China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Hereditary Angioedema Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Hereditary Angioedema Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Hereditary Angioedema Drug Sales Volume Share by Application (2018-2023)
-
Table IBio Inc Company Profile
-
Table IBio Inc Hereditary Angioedema Drug Revenue, Price and Gross (2018-2023)
-
Table CSL Limited Company Profile
-
Table CSL Limited Hereditary Angioedema Drug Revenue, Price and Gross (2018-2023)
-
Table Ionis Pharmaceuticals, Inc Company Profile
-
Table Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Revenue, Price and Gross (2018-2023)
-
Table Shire plc Company Profile
-
Table Shire plc Hereditary Angioedema Drug Revenue, Price and Gross (2018-2023)
-
Table BioCryst Pharmaceuticals, Inc Company Profile
-
Table BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Revenue, Price and Gross (2018-2023)
-
